NCT06200467View on ClinicalTrials.gov

A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

October 22, 2025

Study Completion Date

October 22, 2025

Conditions
OverweightObesity
Interventions
DRUG

BI 456906

Solution for injection

DRUG

Placebo to BI 456906

Solution for injection

DRUG

Moxifloxacin

Film-coated tablet

DRUG

Placebo to moxifloxacin

Film-coated tablet

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT06200467 - A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity | Biotech Hunter | Biotech Hunter